Immune checkpoint inhibitors combined with conventional chemotherapy have led to significantly improved outcomes in the neoadjuvant and perioperative treatment of non-small cell lung cancer (NSCLC), establishing chemoimmunotherapy as the standard of care for p... ...

请注册登录后继续浏览